Articles On Telix Pharmaceuticals (ASX:TLX)

Were you invested in ASX 200 shares vs. property last year? Let's examine which S&P/ASX 200 Index (ASX: XJO) companies experienced the best share price growth and which suburban property markets delivered the best capital gains for...

On Monday, the S&P/ASX 200 Index (ASX: XJO) started the week in a disappointing fashion. The benchmark index sank 1.2% to 8,191.9 points. Will the market be able to bounce back from this on Tuesday? Here are five things to watch: ASX...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Jan. 13, 2025 /PRNewswire/ — Telix Pharmac...

Telix enters into asset purchase agreement with antibody engineering company ImaginAb Lumos joins forces with MedPro for national contract sales coverage of FebriDx in US  4D Medical secures US Department of Defense contract to supply C...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and LIÈGE, Belgium, Jan. 13, 2025 /PRNewswire/ — Telix Pharm...

Melbourne-based biotech Telix Pharmaceuticals (ASX: TLX) is planning to expand its suite of next-generation drug candidates through the acquisition of US-based antibody engineering company ImaginAb for US$45 million ($73 million). The deal...

The Aussie market has kicked off the week lower after an unexpected jump in new U.S. jobs jettisoned any near-term hopes of a rate cut by the Fed Reserve. Back home, jobs ads rose by just 0.3%, having a negligible impact on the bourse....

S&P/ASX 200 Index (ASX: XJO) healthcare stock Telix Pharmaceuticals Ltd (ASX: TLX) is slipping today. Shares in the diagnostic and therapeutic product developer closed on Friday trading for $23.99. In morning trade on Monday, shares...

Telix Pharmaceuticals Ltd (ASX:TLX) is adding to its portfolio of early-stage drug candidates, in addition to a suite of other assets, through a $73 million asset buy agreement with antibody engineering company ImaginAb, Inc. A further $...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Jan. 13, 2025 /PRNewswire/ — Telix Pharmac...

S&P/ASX All Ordinaries Index (ASX: XAO) shares rose by 7.55% last year and delivered total gross returns, including dividends, of 11.44%. The index closed the year at 8,420.5 points. In comparison, the benchmark S&P/ASX 200 Inde...

Let's look back and see which ASX shares vs. property markets delivered the best capital gains in 2024. Shall we start with stocks? ASX 200 shares up more than 7% in 2024 The benchmark S&P/ASX 200 Index (ASX: XJO) lifted 7.49...

Ausbiotech is developing a pre-budget wish list to tackle the sector’s “stubborn issues” CEO Bek Cassidy says the sector’s record at commercialising products is better than portrayed, but it still needs some help. No fewer than 2900 organi...

ASX 200 healthcare shares performed well in 2024, with the S&P/ASX 200 Health Care Index (ASX: XHJ) rising 6.01% and delivering a 12-month total return, including dividends, of 7.51%. However, the healthcare sector did underperform t...

The Vanguard Australian Shares Index ETF (ASX: VAS) delivered a total gross return of 11.4% in 2024. This comprised approximately 7.75% in capital growth and a dividend yield of about 3.65%, excluding franking credits, based on prelimin...

Highlights Market Movements: ASX futures indicate a 0.9% decline; global markets see subdued activity due to New Year closures. Top and Bottom Performers: Key ASX gainers include Zip Co (ASX: ZIP) with a 363% surge, while Liontown Re...

The S&P/ASX 200 Index (ASX: XJO) was on form in 2024 and rose approximately 7.5% to 8,159.1 points. And including dividends, the benchmark index delivered a return in the region of 11.2%. While this is a strong return and ahead of his...

The ASX is barrelling towards closing out 2024 with another red day on New Year’s Eve, but that doesn’t mean the year as a whole was a bloodbath – in fact, for much of the Aussie index it’s been quite the year to remember. Even more so,...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and BRUSSELS, Dec. 31, 2024 /PRNewswire/ — Telix Pharmaceu...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Dec. 30, 2024 /PRNewswire/ — Telix Pharmac...

On Friday, the S&P/ASX 200 Index (ASX: XJO) finished the week on a positive note. The benchmark index rose 0.5% to 8,261.8 points. Will the market be able to build on this on Monday? Here are five things to watch: ASX 200 expected to...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Dec. 19, 2024 /PRNewswire/ — Telix Pharmac...

It was a bit of a disappointing hump day session for the S&P/ASX 200 Index (ASX: XJO) this Wednesday. After spending most of the morning in green territory, investors got cold feet a...

It was a fairly nasty start to the trading week for the S&P/ASX 200 Index (ASX: XJO) and many ASX shares this Monday. After a rough week last week, investors clearly didn't get their m...

Anteris shares have commenced trading on the Nasdaq exchange 4D Medical snags another US lung imaging contract Anatara reports more than enough irritable bowel trial takers   Shares in heart valve innovator Anteris Technologies (ASX:AVR...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin In Brief has filled the Christmas stocking with great stock snacks for investors, Pr...

The S&P/ASX 200 Index (ASX: XJO) has just closed November at 8,436.2 points. This means the benchmark index is up 11.1% since the start of the year. While this is an impressive return, some ASX 200 shares have managed to significantly...

It was a rather lacklustre end to the trading week this Friday as investors closed off a wild and woolly November of ASX trading. The S&P/ASX 200 Index (ASX: XJO) fell in value today, but on...

The All Ordinaries Index (ASX: XAO) is down 0.3% in early afternoon trade on Friday, but that's not holding back these fast-rising ASX All Ords shares. Some of these stocks are hitting new all-time high territory today, while others are...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Nov. 28, 2024 /PRNewswire/ – Telix Pharmaceuticals Limited...

Somnomed shares soar 28% on this morning’s upgrade  Biome tells a revenue growth story in a few words 2a and now 2b, says Island – with safety not a question A corporate ‘reset’ at sleep disorders house Somnomed (ASX:SOM) looks to be pay...

The S&P/ASX 200 Index (ASX: XJO) copped a not-so-nice sell-off this Tuesday, reversing some of the optimism that we've been seeing on the Australian markets in recent days. The ASX 200 finis...

Robert F Kennedy Junior’s appointment as US health czar means an unpredictable time for ASX healthcare companies operating in the US The likely consequences are not all bad, with many stocks poised to benefit from tax cuts and a more effic...

The S&P/ASX 200 Index (ASX: XJO) is having a strong session on Tuesday and is storming higher. At the time of writing, the benchmark index is up 1% to 8,384.9 points. Four ASX shares that have failed to follow the market higher today a...

Sonic reaffirms earnings guidance and says it is on the hunt for “sensible” acquisitions Boards face their inquisitors in peak AGM week Resonance shares soar on Sun Pharma deal   Pathology and radiology giant Sonic Healthcare (ASX:SHL) sa...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Nov. 19, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited...

Harvard University’s teaching hospital will adopt Echo IQ’s AI-based aortic stenosis detection tool Immuron trots out its Travelan agenda at its AGM Oncosil goes hot and cold with latest distribution deals   Echo IQ (ASX:EIQ) has won the...

Amid improving sector sentiment, Actinogen says its Alzheimer’s trial is off to a flier Telix shares start trading on the Nasdaq tonight More of the Trump-edelic effect? Tryptamine shares are on a roll   Actinogen Medical (ASX:ACW) report...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and BERLIN, Germany, Nov. 13, 2024 /PRNewswire/ — Telix Phar...

It's been a rough session for the S&P/ASX 200 Index (ASX: XJO) and many ASX 200 shares so far this Tuesday. At the time of writing, the ASX 200 has retreated by a hefty 0.4% and is back under 8,240 points. But the broader market's fall...

Wellnex Life Ltd (ASX:WNX) has unveiled its plans to defer a $2.95M payment to 360 Health until it lists on the London exchange in January. Following its acquisition of topical pain relief product brand Pain Way, the cannabis-focused he...

Highlights ASX200 closed up, led by gains in IT and Utilities sectors. Leadership shake-up affects Mineral Resources, with major stock impact. Future Battery Minerals, Telix Pharmaceuticals see notable moves in the green.  The AS...

Highlights   ASX closed with a 0.56% gain, boosted by Utilities and IT sectors.   Notable gains for West Gold Resources Ltd and Telix Pharmaceuticals Ltd.   Small caps like Yandal Resources Ltd saw significant intra-day highs. The...

The ASX200 closed up 0.56% at 8164 points. In a tumultuous day on the market, Chris Ellison’s Mineral Resources shed 9.63% after it was dramatically revealed he will exit the business. The board ultimately lost confidence in him and says...

Highlights  ASX rises as banks drive gains amid strong Wall Street influence.  MinRes faces major drop following founder controversy. RBA decision and US rate outlook keep markets focused. The Australian stock market showed positi...

It was a very pleasant start to what is shaping up to be a big trading week for the S&P/ASX 200 Index (ASX: XJO) this Monday. After a sobering conclusion to last week's trading, investors seem...

  ASX closes higher despite Mineral Resources dip US dollar weakens amid uncertain election polling Ordell, Blue Star Helium star for small caps   The ASX closed Monday higher by 0.5%, riding the wave of optimism from Wall Street.  Howev...

The S&P/ASX 200 Index (ASX: XJO) is starting the week strongly. In afternoon trade, the benchmark index is up 0.5% to 8,161.7 points. Four ASX shares that are rising more than most today are listed below. Here's why they are climbing:...

Highlights    ASX gains slightly amid mixed performances in key sectors   Mineral Resources drops on leadership change, dragging mining sector   Energy sector declines despite oil price rally   The Australian share market experien...

Telix Pharmaceuticals will benefit from ongoing favourable US pay arrangements for high-value radiopharmaceutical diagnostics Optiscan teams with Monash University to develop a next-gen endomicroscope – and AI is involved BOD Australia inv...